YOCHAI BIRNBAUM to Diabetic Ketoacidosis
This is a "connection" page, showing publications YOCHAI BIRNBAUM has written about Diabetic Ketoacidosis.
Connection Strength
0.165
-
SGLT2 Inhibition by Dapagliflozin Attenuates Diabetic Ketoacidosis in Mice with Type-1 Diabetes. Cardiovasc Drugs Ther. 2022 12; 36(6):1091-1108.
Score: 0.165
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.